BIOPHARMASPEC (UK) LIMITED
Registered number: 09031531
Dormant Accounts
for the period ending: 31 December 2024
Balance Sheet
as at 31 December 2024
| 2024 |  | 2023 |
| £ |  | £
| Assets
| Unpaid called up share capital, classed as current asset | 10.00 |  | 10.00
| Cash at bank and in hand | 0.00 |  | 0.00
| Net assets | 10.00 |  | 10.00
| Issued Share Capital
| 10 Ordinary Shares of £ 1 each | 10.00 |  | 10.00
| Total Shareholder funds | 10.00 |  | 10.00
Statements
For the period ending 31 December 2024 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions.
Approved by the board on 19 June 2025
Howard Redfern MORRIS - Director

FirstOrder by First Corporate August 2022 BIOPHARMASPEC (UK) LIMITED 09031531 true 2024-01-01 2024-12-31 2024-12-31 Howard Redfern MORRIS false 09031531 2024-01-01 2024-12-31 09031531 bus:Director1 2024-01-01 2024-12-31 09031531 2024-12-31 09031531 2024-01-01 09031531 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 09031531 bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 09031531 bus:Micro-entities 2024-01-01 2024-12-31 09031531 bus:EntityHasNeverTraded 2024-01-01 2024-12-31 09031531 bus:FullAccounts 2024-01-01 2024-12-31 iso4217:GBP xbrli:shares